Haemonetics
180 hedge funds and large institutions have $1.87B invested in Haemonetics in 2016 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 67 increasing their positions, 63 reducing their positions, and 22 closing their positions.
25% more capital invested
Capital invested by funds: $1.5B → $1.87B (+$369M)
14% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 22
2% more funds holding
Funds holding: 177 → 180 (+3)
6% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 63
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.21% less ownership
Funds ownership: 101.22% → 101.01% (-0.21%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$30.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.5M |
| 3 |
ACM
American Capital Management
New York
|
+$19.7M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$17.1M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
-$22.7M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$21M |
| 3 |
Millennium Management
New York
|
-$12.8M |
| 4 |
ACA
Anchor Capital Advisors
Boston,
Massachusetts
|
-$11.1M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$10.9M |
HAE Hedge Fund Activity: Q3 2016 in Review
180 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q3 2016, worth a combined $1.87B — up 25% from $1.5B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new HAE positions and 22 closed out — a net gain of 3 holders — while 67 added to existing stakes and 63 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $30.2M. The largest seller was Black Creek Investment Management, cutting an estimated $22.7M.
- 180 institutional investors held Haemonetics (HAE) as of Q3 2016, up from 177 in Q2 2016.
- Funds reported $1.87B of Haemonetics stock for Q3 2016, up 25% quarter-over-quarter.
- 25 funds opened new Haemonetics positions in Q3 2016 and 22 closed out, a net change of +3 holders.
- The largest Haemonetics buyer in Q3 2016 was Wellington Management Group, an estimated $30.2M added.
- The largest Haemonetics seller in Q3 2016 was Black Creek Investment Management, an estimated $22.7M sold.
Based on aggregated 13F filings for Q3 2016.